Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RENUBI Immune Ace is a health functional supplement developed by the South Korean company **PICO Entech**. The product is formulated as a combination of **red ginseng** and **ALDH (Aldehyde Dehydrogenase) dried yeast**. It is marketed for multiple health benefits, including immune system enhancement, fatigue recovery, improvement of blood flow through the inhibition of platelet aggregation, and memory improvement. The core of the formulation is PICO Entech's proprietary ALDH technology, which utilizes dried yeast containing active aldehyde dehydrogenase enzymes to support metabolic processes and overall physiological resilience.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on RENUBI Immune Ace.